Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Oncology
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| keytruda qlex | Merck & Co., Inc. (MRK) |
Phase 1(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma?
BioSniper tracks 3 drugs in development for Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma across 1 company.
How many clinical trials target Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma?
There are 1 clinical trial targeting Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma tracked by BioSniper.
Deep-dive into Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis